Richard Berendt
Overview
Explore the profile of Richard Berendt including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
16
Citations
162
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Krishnan P, Ghosh S, Wang B, Li D, Narasimhan A, Berendt R, et al.
BMC Genomics
. 2015 Sep;
16:735.
PMID: 26416693
Background: Prognostication of Breast Cancer (BC) relies largely on traditional clinical factors and biomarkers such as hormone or growth factor receptors. Due to their suboptimal specificities, it is challenging to...
12.
Joseph K, Vrouwe S, Kamruzzaman A, Balbaid A, Fenton D, Berendt R, et al.
World J Surg Oncol
. 2012 Jun;
10:118.
PMID: 22734852
Background: To analyze the characteristics and outcomes of women with breast cancer in the Northern Alberta Health Region (NAHR) who declined recommended primary standard treatments. Methods: A chart review was...
13.
Copete M, Garratt J, Gilks B, Pilavdzic D, Berendt R, Bigras G, et al.
J Clin Pathol
. 2011 Jan;
64(3):220-5.
PMID: 21258091
Aims: Pan-cytokeratin (pan-CK) and low molecular weight cytokeratin (LMWCK) tests are the most common immunohistochemistry (IHC) tests used to support evidence of epithelial differentiation. Canadian Immunohistochemistry Quality Control (CIQC), a...
14.
Torlakovic E, Riddell R, Banerjee D, El-Zimaity H, Pilavdzic D, Dawe P, et al.
Am J Clin Pathol
. 2010 Feb;
133(3):354-65.
PMID: 20154273
Immunohistochemical and immunocytochemical assays are highly complex diagnostic analyses used to aid in the accurate identification and biologic characterization of tissue types in neoplastic and nonneoplastic diseases. Immunohistochemical tests are...
15.
Terry J, Torlakovic E, Garratt J, Miller D, Kobel M, Cooper J, et al.
Appl Immunohistochem Mol Morphol
. 2009 Apr;
17(5):375-82.
PMID: 19363444
Immunohistochemistry results for estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 are used to guide breast carcinoma patient management and it is essential to monitor these tests...
16.
Thoms J, Berendt R, Pearcey R
Oncology (Williston Park)
. 2008 Oct;
22(10):1143-5.
PMID: 18935926
The incidence of distant recurrent metastatic primary vaginal carcinoma is rare. The prognosis in such cases is poor, with cure being extremely rare. We report the case of a young...